Shares of Glanbia plc (OTCMKTS:GLAPF – Get Free Report) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $23.33 and traded as high as $25.8980. Glanbia shares last traded at $25.8980, with a volume of 200 shares.
Wall Street Analysts Forecast Growth
Several research firms recently commented on GLAPF. Barclays reiterated an “overweight” rating on shares of Glanbia in a research note on Wednesday, June 17th. Oddo Bhf downgraded Glanbia to a “neutral” rating in a research report on Wednesday, July 15th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Glanbia in a research note on Friday, June 26th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, Glanbia has a consensus rating of “Moderate Buy”.
View Our Latest Stock Report on GLAPF
Glanbia Trading Down 7.0%
Glanbia Company Profile
Glanbia plc is a global nutrition group headquartered in Kilkenny, Ireland, with roots tracing back to the merger of Avonmore and Waterford agricultural cooperatives in 1997. The company is organized around two main divisions: Performance Nutrition, which focuses on sports and lifestyle-forward consumer products, and Glanbia Nutritionals, which supplies nutritional ingredients and custom formulation services to food, beverage and pharmaceutical customers.
Under its Performance Nutrition arm, Glanbia markets well-known brands of protein powders, bars and ready-to-drink beverages designed for athletes, fitness enthusiasts and wellness-focused consumers.
See Also
- Five stocks we like better than Glanbia
- 3 Low-P/E Stocks That Look Cheap as the S&P 500 Trades Near Record Highs
- Travel + Leisure Goes Big—Is It Ready to Rally?
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
Receive News & Ratings for Glanbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glanbia and related companies with MarketBeat.com's FREE daily email newsletter.
